Nymox Pharmaceutical Corp
NYMX
NYMX was delisted on the 6th of July, 2023.
30 hedge funds and large institutions have $2.48M invested in Nymox Pharmaceutical Corp in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 5 closing their positions.
80% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 5
47% more call options, than puts
Call options by funds: $1.04M | Put options by funds: $707K
13% more capital invested
Capital invested by funds: $2.2M → $2.48M (+$283K)
0.21% more ownership
Funds ownership: 1.3% → 1.51% (+0.21%)
3% less funds holding
Funds holding: 31 → 30 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$155K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$107K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$80.8K |
| 4 |
Morgan Stanley
New York
|
+$71.2K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$44.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WS
Wedbush Securities
Los Angeles,
California
|
-$101K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
-$36K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$27.2K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$24K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$16.4K |
NYMX Hedge Fund Activity: Q3 2016 in Review
30 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q3 2016, worth a combined $2.48M — up 13% from $2.2M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of NYMX and 4 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 9 added.
The largest buyer was Susquehanna International Group, adding an estimated $155K. The largest seller was Wedbush Securities, cutting an estimated $101K.
- 30 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q3 2016, down from 31 in Q2 2016.
- Funds reported $2.48M of Nymox Pharmaceutical Corp stock for Q3 2016, up 13% quarter-over-quarter.
- 4 funds opened new Nymox Pharmaceutical Corp positions in Q3 2016 and 5 closed out, a net change of -1 holder.
- The largest Nymox Pharmaceutical Corp buyer in Q3 2016 was Susquehanna International Group, an estimated $155K added.
- The largest Nymox Pharmaceutical Corp seller in Q3 2016 was Wedbush Securities, an estimated $101K sold.
Based on aggregated 13F filings for Q3 2016.